An association between aspirin use in human cases of infective endocarditis and reduced systemic embolism is shown in meta-analysis of observational studies
Journal Contribution ResearchOnline@JCUAbstract
[Extract] Animal studies such as published recently in this journal [1] show benefits of antiplatelet agents in experimental models of Staphylococcus aureus infective endocarditis (IE). It is, therefore, important to consider how these experimental data translate into clinical practice. A number of human studies have considered this area, concentrating almost exclusively on long-term aspirin usage. We have performed a meta-analysis of these 9 published studies [2–10] to assess whether the data may provide a basis for future trials and possibly change Infectious Diseases Society of America guidelines that recommend that aspirin should not be used in IE.
Journal
Journal of Infectious Diseases
Publication Name
N/A
Volume
212
ISBN/ISSN
1537-6613
Edition
N/A
Issue
4
Pages Count
2
Location
N/A
Publisher
University of Chicago Press
Publisher Url
N/A
Publisher Location
N/A
Publish Date
N/A
Url
N/A
Date
N/A
EISSN
N/A
DOI
10.1093/infdis/jiv131